Loading...
Platelet Count Measured Prior to Cancer Development Is a Risk Factor for Future Symptomatic Venous Thromboembolism: The Tromsø Study
BACKGROUND: Elevated platelet count is associated with risk of venous thromboembolism in cancer patients initiating chemotherapy. It is not known whether this risk by platelet count is causal or merely reflects the malignant disease. We investigated whether pre-cancer platelet count alone or togethe...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Public Library of Science
2014
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3958406/ https://ncbi.nlm.nih.gov/pubmed/24642868 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0092011 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|